These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10065111)

  • 41. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.
    Bacigalupo A; Giammarco S; Sica S
    Int J Hematol; 2016 Aug; 104(2):168-74. PubMed ID: 27278666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late graft rejection and second infusion of bone marrow in children with aplastic anaemia.
    Eapen M; Davies SM; Ramsay NK
    Br J Haematol; 1999 Jan; 104(1):186-8. PubMed ID: 10027732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor.
    Vo PT; Pantin J; Ramos C; Cook L; Cho E; Kurlander R; Khuu H; Barrett J; Leitman S; Childs RW
    J Hematol Oncol; 2015 Jun; 8():78. PubMed ID: 26113077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
    Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.
    Bacigalupo A; Brand R; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint MT; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
    Semin Hematol; 2000 Jan; 37(1):69-80. PubMed ID: 10676912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Severe acquired aplastic anemia: historical outcome of patients treated by allogeneic bone marrow transplantation from matched sibling donors. A study by the Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
    Muñoz Villa A; Díaz de Heredia C; Díaz González MA; Badell Serra I; Martínez Rubio A; González Valentín MA; Dasí Carpio MA; Gómez Pérez P; Bureo Dacal E; Olivé Oliveras T; Pérez Hurtado JM; Maldonado Regalado MS
    An Pediatr (Barc); 2008 Jul; 69(1):5-9. PubMed ID: 18620669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
    Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
    Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
    Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
    Locasciulli A; Oneto R; Bacigalupo A; Socié G; Korthof E; Bekassy A; Schrezenmeier H; Passweg J; Führer M;
    Haematologica; 2007 Jan; 92(1):11-8. PubMed ID: 17229630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant.
    Stute N; Fehse B; Schröder J; Arps S; Adamietz P; Held KR; Zander AR
    J Hematother Stem Cell Res; 2002 Dec; 11(6):977-84. PubMed ID: 12590713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
    Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy.
    Tzeng CH; Chen PM; Chuang MW; Liu JH; Hsieh RK; Liu CJ; Fan S; Chen KY; Yung CH; Wang SY
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):21-8. PubMed ID: 2670137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
    Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
    Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
    Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
    Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.